Related references
Note: Only part of the references are listed.Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC
Jian Huang et al.
ONCOGENE (2020)
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
Ritika Tiwari et al.
NATURE COMMUNICATIONS (2020)
Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response
Sidika Oztop et al.
ANTICANCER RESEARCH (2019)
Innervation of cervical carcinoma is mediated by cancer-derived exosomes
Christopher T. Lucido et al.
GYNECOLOGIC ONCOLOGY (2019)
Concise Review: Prostate Cancer Stem Cells: Current Understanding
Sergej Skvortsov et al.
STEM CELLS (2018)
Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
Jose Marrugo-Ramirez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapy
Hao Geng et al.
NATURE COMMUNICATIONS (2018)
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
Marzia Del Re et al.
EUROPEAN UROLOGY (2017)
Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers
Fermín Person et al.
TUMOR BIOLOGY (2017)
Biomarkers from liquid biopsy
Louise Stone
Nature Reviews Urology (2016)
βIII-Tubulin Regulates Breast Cancer Metastases to the Brain
Deepak Kanojia et al.
MOLECULAR CANCER THERAPEUTICS (2015)
βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer
Joshua A. McCarroll et al.
ONCOTARGET (2015)
Tubulin--III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones
Dana M. Roque et al.
CANCER (2013)
Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Marisa Mariani et al.
CLINICAL CANCER RESEARCH (2012)
Identification of class III β-tubulin as a marker of angiogenic perivascular cells
Peter C. Stapor et al.
MICROVASCULAR RESEARCH (2012)
Expression of Tubb3, a Beta-Tubulin Isotype, Is Regulated by Androgens in Mouse and Rat Sertoli Cells
Karel De Gendt et al.
BIOLOGY OF REPRODUCTION (2011)
Class III β-Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
M. Mariani et al.
CURRENT MOLECULAR MEDICINE (2011)
HuR Regulates β-Tubulin Isotype Expression in Ovarian Cancer
Giuseppina Raspaglio et al.
CANCER RESEARCH (2010)
Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
Guillaume Ploussard et al.
CANCER RESEARCH (2010)
Increased expression of class III β-tubulin in castration-resistant human prostate cancer
S. Terry et al.
BRITISH JOURNAL OF CANCER (2009)
Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
Giuseppina Raspaglio et al.
GENE (2008)
Class III β-tubulin mediates sensitivity to chemotherapeutic drugs in non-small cell lung cancer
Pei Pei Gan et al.
CANCER RESEARCH (2007)
Class III β-tubulin in human development and cancer
CD Katsetos et al.
CELL MOTILITY AND THE CYTOSKELETON (2003)
Share Paper
